Key points are not available for this paper at this time.
Fracture-risk screening is indicated with initiation of glucocorticoids. If the risk is high because of age, bone mineral density, or the fracture risk assessment tool score, pharmacologic treatment is recommended; bisphosphonates are recommended as first-line treatment.
Buckley et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: